EV/EBITDA
Updated 80h ago
Sector Performance
60th percentileRSG
15.7x
Sector Median
13.7x
Sector Avg
18.7x
Deep Analysis
The current EV/EBITDA of 15.7x means that for every dollar of RSG’s operating profit (EBITDA), investors are paying $15.70 of enterprise value — a measure of the company’s total worth including debt.
This ratio is above the sector median of 13.6x, placing RSG in the 60th percentile among its peers, indicating it trades at a premium relative to similar companies. Over the past year, the metric has increased by 20.3%, and over the latest quarter it rose 0.3%, continuing an upward trend observed across the last eight quarters. A valuation above the sector median combined with a steadily rising trend suggests that growth expectations are already priced in, making the stock more sensitive to any earnings disappointments — a potential risk for investors. This elevated and climbing EV/EBITDA does not contradict the overall NEUTRAL verdict, as it supports a balanced view: the premium reflects confidence in the company’s performance but also leaves limited room for error.
Frequently Asked Questions
What does the EV/EBITDA tell investors about RSG?
A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.
How is the EV/EBITDA calculated?
EV/EBITDA is calculated as: Enterprise Value / EBITDA.
Who are RSG's closest peers by EV/EBITDA?
The closest peers by EV/EBITDA include: LSPD (-24.2x), BRZE (-24.5x), EVGO (-25.7x), NIO (-36.8x), SNAP (-38.8x).
The Formula
Enterprise Value / EBITDA
Why It Matters
A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.
Master RSG's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RSG research report →RSG
15.7x
Sector Median
13.7x
Sector Avg
18.7x
How RSG's EV/EBITDA compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.